Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody

By Galili U.   Repik P.M.   Anaraki F.   Mozdzanowska K.   Washko G.   Gerhard W.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 321-328

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with synthetic recombinant vaccine containing multiple epitopes of influenza virus

By Jeon S.H.   Ben-Yedidia T.   Arnon R.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2772-2780

Elsevier

Access to resources Recommend Favorite

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

By Moldoveanu Z.   Clements M.L.   Prince S.J.   Murphy B.R.   Mestecky J.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 1006-1012

Elsevier

Access to resources Recommend Favorite

Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms&unknown;) and oil-in-water vaccines

By Coulter A.   Wong T.-Y.   Drane D.   Bates J.   Macfarlan R.   Cox J.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1243-1253

Elsevier

Access to resources Recommend Favorite

Anti-alpha-Gal antibody titres remain unaffected by the consumption of fermented milk containing Lactobacillus casei in healthy adults

By Mangold Andreas   Hercher David   Hlavin Gerald   Liepert Julia   Zimmermann Matthias   Kollmann Dagmar   Feichtinger Georg   Lichtenauer Michael   Mitterbauer Andreas   Ankersmit Hendrik Jan  

International Journal of Food Sciences and Nutrition, Vol. 63, Iss. 3, 2012-05 ,pp. : 278-282

Informa Healthcare

Access to resources Recommend Favorite